PVLA Palvella Therapeutics, Inc. - Common Stock
$152,77
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 4, 2026
52W-Spanne
$46–$161
93% of range
Analystenbewertung
BUY
22 analysts
Kursziel
$231
+51% upside
P/E (TTM)
-41.2
ROE
-110.1%
Nettogewinnmarge
-1610.6%
PVLA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$152.77
Marktkapitalisierung
$1.89B
P/E (TTM)
-41.2
EPS (TTM)
$-3.71
Umsatz (TTM)
$43M
Dividendenrendite
—
ROE
-110.1%
Verschuldungsgrad
—
52W-Spanne
$46 – $161
PVLA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$43M
2017-12-31
→
2023-12-31
EPS
$-3.71
2020-12-31
→
2025-12-31
Freier Cashflow
—
2017-12-31
→
2022-12-31
Margen
-1610.6%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
PVLA
Peer-Median
P/E (TTM)
-41.2
55.4
P/S (TTM) (K/V (TTM))
96.6
7.7
P/B (K/B)
67.6
7.1
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
PVLA
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-1490.4%
—
Net Profit Margin (Nettogewinnmarge)
-1610.6%
-2.0%
ROA
-56.5%
-32.7%
ROE
-110.1%
-37.9%
ROIC
-137.9%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
PVLA
Peer-Median
Current Ratio (Liquiditätsgrad)
5.2
7.4
Quick Ratio
5.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
PVLA
Peer-Median
Revenue YoY (Umsatz YoY)
65.3%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
13.4%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
PVLA
Peer-Median
PVLA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
22 Analysten
- Starker Kauf 6 27,3%
- Kauf 15 68,2%
- Halten 1 4,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
15 Analysten · 2026-08-17
Median
$232.00
← Unter allen Zielen
$152.77
Tief
$205.00
Hoch
$270.00
Median-Ziel
$232.00
+51,9%
Mittelwert-Ziel
$230.53
+50,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.37%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-1.52 | $-1.18 | -0.34% |
| 31. März 2026 | $-1.20 | $-0.95 | -0.25% |
| 31. Dezember 2025 | $-1.07 | $-0.93 | -0.14% |
| 30. September 2025 | $-1.03 | $-0.86 | -0.17% |
| 30. Juni 2025 | $-0.86 | $-0.76 | -0.10% |
| 31. März 2025 | $-0.74 | $-1.24 | 0.50% |
| 31. Dezember 2024 | $-2.72 | $-0.66 | -2.1% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| VERA | — | -10.9 | — | — | -55.9% | — |
| MLYS | $2.96B | -15.8 | — | — | -32.2% | — |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| R&D Expense | $23M | $8M | $9M | $53M | $67M | $47M | $55M | $41M | $22M | $20M | $8M | $6M | |
| SG&A Expense | $16M | $6M | $3M | $16M | $17M | $17M | $18M | $18M | $18M | $9M | $8M | $7M | |
| Operating Expenses | $39M | $14M | $12M | $69M | $83M | $63M | $73M | $60M | $40M | $29M | $17M | $13M | |
| Operating Income | $-39M | $-14M | $-12M | $-43M | $-52M | $-34M | $-27M | $-31M | $-15M | $-23M | $-14M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Other Non-op | $727.0K | $-131.0K | $712.0K | $1M | $2M | $-4M | $-26.0K | $2M | $-2M | $120.0K | $10.9K | $3.0K | |
| Pretax Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-17M | $-23M | $-14M | $-10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $164.0K | $0 | $-312.0K | $1M | $162.0K | $203.9K | $-18 | |
| Net Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| EPS (Basic) | $-3.71 | $-7.83 | $2.19 | $-0.45 | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.71 | $-7.83 | $2.17 | · | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| Shares (Basic) | 11,251,250 | 2,225,934 | 1,770,167 | 74,172,000 | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 11,251,250 | 2,225,934 | 1,793,980 | · | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| EBITDA | $-39M | $-14M | · | $-41M | · | $-34M | $-27M | $-31M | $-15M | · | · | · |
Bilanz 24
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $84M | $7M | $39M | $118M | $70M | $62M | $75M | $38M | $29M | $29M | $18M | |
| Short-term Investments | $0 | · | $9M | $21M | $0 | $0 | $42M | $53M | $35M | $0 | · | · | |
| Receivables | $0 | $358.0K | $0 | $6M | $3M | $2M | $7M | $3M | $16M | $57.0K | $0 | $0 | |
| Prepaid Expense | $1M | $2M | $198.0K | $3M | $7M | $4M | $4M | $5M | $2M | $3M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $59M | $88M | $8M | $73M | $128M | $76M | $115M | $135M | $90M | $33M | $32M | $20M | |
| PP&E (Net) | · | · | $0 | $17M | $19M | $22M | $20M | $5M | $4M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | · | $27M | $27M | $28M | $23M | $8M | $7M | $5M | $4M | $4M | |
| Accum. Depreciation | · | · | · | $10M | $8M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | $0 | $1M | $3M | $3M | $3M | $910.0K | $130.0K | $126.0K | $126.8K | · | |
| Total Assets | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Accounts Payable | $5M | $5M | $936.0K | $4M | $9M | $2M | $6M | $3M | $2M | $2M | $1M | · | |
| Accrued Liabilities | · | · | · | · | · | $8M | $10M | $9M | $6M | $4M | $2M | $986.6K | |
| Current Liabilities | $11M | $12M | $2M | $37M | $51M | $22M | $27M | $48M | $46M | $8M | $3M | $4M | |
| Capital Leases | $431.0K | $0 | $0 | $12M | $14M | $16M | $15M | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | $6.0K | $0 | $27.0K | $37.0K | $47.0K | $23.9K | $334.0K | |
| Total Liabilities | $32M | $26M | $11M | $68M | $103M | $74M | $90M | $101M | $92M | $10M | $3M | $4M | |
| Common Stock | $12.0K | $11.0K | $0 | $74.0K | $72.0K | $56.0K | $55.0K | $54.0K | $45.0K | $43.0K | $39.8K | $29.3K | |
| Paid-in Capital | $163M | $156M | $2M | $319M | $307M | · | · | · | · | · | $112M | $85M | |
| Retained Earnings | $-135M | $-94M | $-76M | $-290M | $-257M | $-211M | $-174M | $-147M | $-120M | $-103M | $-80M | $-66M | |
| AOCI | $83.0K | $3.0K | $0 | $-254.0K | $829.0K | $-295.0K | $-2M | $-3M | $-5M | $-2M | $-1M | $-843.1K | |
| Stockholders' Equity | $28M | $63M | $-74M | $-94M | $51M | $31M | $51M | $40M | $12M | $25M | $31M | $18M | |
| Liabilities + Equity | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Shares Outstanding | 12,380,933 | 11,012,105 | 1,770,167 | 74,519,103 | 72,222,661 | 56,003,000 | 55,212,437 | 54,151,219 | 45,017,062 | 43,058,827 | 39,833,023 | 29,279,522 |
Cashflow 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2M | $3M | $2M | · | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $830.0K | $603.0K | $4M | $5M | $5M | $5M | $5M | $3M | $2M | $1M | $571.4K | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $0 | $-164.0K | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | $-34M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-11M | $-14M | $-60M | $-8M | $-46M | $-52M | $-1M | $50M | $-14M | $-13M | $-5M | |
| CapEx | · | · | $171.0K | $1M | $949.0K | $3M | $2M | $2M | $2M | $560.0K | $620.7K | $267.4K | |
| Investing Cash Flow | · | · | $12M | $-21M | $-949.0K | $39M | $10M | $-9M | $-46M | · | · | · | |
| Stock Issued | · | · | $20M | $7M | $38M | $10M | · | · | · | · | $26M | $12M | |
| Net Stock Activity | · | · | · | $7M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-660.0K | $87M | $5M | $7M | $59M | $10M | $32M | $49M | $4M | · | · | · | |
| Net Change in Cash | $-26M | $76M | $-9M | $-79M | $47M | $8M | $-13M | $37M | $9M | $6.0K | $11M | $15M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $51.7K | |
| Free Cash Flow | · | · | · | $-61M | · | $-49M | $-55M | $-3M | $48M | · | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1490.4% | · | · | -167.8% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| Net Margin | -1610.6% | · | · | -128.5% | · | -127.0% | -55.0% | -91.9% | -69.8% | · | · | · | |
| Pretax Margin | -1610.6% | · | · | -128.5% | · | -126.4% | -55.0% | -93.0% | -65.5% | · | · | · | |
| EBITDA Margin | -1490.4% | · | · | -157.1% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| ROA | -56.5% | -36.4% | · | -26.7% | · | -30.3% | -17.9% | -21.8% | -25.4% | · | · | · | |
| ROE | -110.1% | 140.6% | · | -92.1% | · | -99.7% | -70.8% | -59.3% | -96.0% | · | · | · | |
| ROIC | -137.9% | -22.5% | · | -155.7% | · | -109.8% | -52.9% | -76.3% | -135.1% | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 7.3 | · | 2.0 | · | 3.4 | 4.3 | 2.8 | 2.0 | · | · | · | |
| Quick Ratio | 5.1 | 7.0 | · | 1.8 | · | 3.3 | 4.1 | 2.7 | 1.9 | · | · | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.2 | · | 0.2 | 0.3 | 0.2 | 0.4 | · | · | · | |
| Receivables Turnover | 14.5 | · | · | 5.7 | · | 6.9 | 9.8 | 3.2 | 3.2 | · | · | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 65.3% | -17.6% | 7.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | 13.4% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| Net Income TTM | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| Market Cap | $1.30B | $132M | · | $6.20B | · | $11.20B | $15.99B | $11.52B | $27.19B | · | · | · | |
| P/E | -28.2 | -1.5 | 6.7 | -118.9 | -425.9 | -294.1 | · | · | · | · | · | · | |
| P/S | 66.2 | 6.8 | · | 239.4 | · | 382.0 | 345.5 | 396.0 | 1075.8 | · | · | · | |
| P/B | 46.3 | 2.1 | · | 222.0 | · | 361.0 | 311.4 | 288.6 | 2359.9 | · | · | · | |
| P / Tangible Book | 46.3 | 2.1 | · | · | 430.3 | 361.0 | · | · | · | · | · | · | |
| P / Cash Flow | -51.8 | -12.2 | · | -103.5 | · | -244.0 | -304.8 | -10809.9 | 546.5 | · | · | · | |
| P / FCF | · | · | · | -101.7 | · | -230.4 | -291.1 | -4169.1 | 568.8 | · | · | · | |
| Earnings Yield | -3.5% | -65.2% | 14.9% | -0.84% | -0.23% | -0.34% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $0 | $0 | $53.0K | · | $20M | $20M | $2M | $6M | $5M | |
| R&D Expense | $12M | $9M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $984.0K | $-29M | $10M | $14M | $13M | $13M | $14M | |
| SG&A Expense | $9M | $6M | $4M | $4M | $4M | $4M | $2M | $2M | $1M | $775.0K | $-11M | $7M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $21M | $15M | $11M | $10M | $9M | $8M | $4M | $5M | $3M | $2M | $-55M | $31M | $18M | $17M | $17M | $18M | |
| Operating Income | $-21M | $-15M | $-11M | $-10M | $-9M | $-8M | $-4M | $-5M | $-3M | $-2M | $13M | $-12M | $2M | $-16M | $-12M | $-12M | |
| Other Non-op | $-8.0K | $-32.0K | $-92.0K | $34.0K | $561.0K | $224.0K | $-175.0K | $-20.0K | $64.0K | $0 | $424.0K | $506.0K | $-161.0K | $-57.0K | $-325.0K | $723.0K | |
| Pretax Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | $39M | $-11M | $4M | $-13M | $-8M | $-10M | |
| EPS (Basic) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $21.41 | $-8.70 | $3.63 | $-14.15 | $-0.11 | $-0.13 | |
| EPS (Diluted) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $20.50 | $-8.70 | $3.62 | · | · | · | |
| Shares (Basic) | 14,356,219 | 13,085,271 | -21,879,470 | 11,064,282 | 11,052,741 | 11,013,697 | -3,084,567 | 1,770,167 | 1,770,167 | 1,770,167 | -1,491,833 | 1,236,000 | 1,095,000 | 931,000 | -148,061,000 | 74,397,000 | |
| Shares (Diluted) | 14,356,219 | 13,085,271 | -21,879,470 | 11,064,282 | 11,052,741 | 11,013,697 | -3,084,567 | 1,770,167 | 1,770,167 | 1,770,167 | 704,980 | 1,236,000 | 1,098,000 | · | · | · | |
| EBITDA | $-21M | $-15M | · | $-10M | $-9M | $-8M | · | $-3M | $-4M | $-5M | · | $-12M | $2M | $-15M | · | $-12M |
Bilanz 22
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $188M | $206M | $58M | $64M | $70M | $76M | $84M | $19M | $20M | $19M | $7M | $33M | $45M | $40M | $39M | $48M | |
| Short-term Investments | $63M | $55M | · | · | · | · | · | $0 | $0 | $0 | · | $12M | $10M | $9M | $21M | $21M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $358.0K | $373.0K | $1M | $2M | $0 | $1M | $952.0K | $1M | $6M | $829.0K | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $280.0K | $649.0K | $3M | $198.0K | $9M | $11M | $11M | $3M | $8M | |
| Current Assets | $253M | $263M | $59M | $67M | $74M | $79M | $88M | · | · | · | $8M | $59M | $66M | $61M | $73M | $79M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $0 | $16M | $17M | $17M | $16M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | $27M | $27M | $27M | $24M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | $11M | $10M | $10M | $8M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $287.0K | $1M | $1M | $1M | $1M | |
| Total Assets | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Accounts Payable | $7M | $5M | $5M | $3M | $5M | $4M | $5M | $801.0K | $969.0K | $2M | $936.0K | $3M | $8M | $6M | $4M | $4M | |
| Current Liabilities | $12M | $9M | $11M | $10M | $10M | $9M | $12M | $4M | $6M | $8M | $2M | $29M | $34M | $43M | $37M | $34M | |
| Capital Leases | $318.0K | $375.0K | $431.0K | · | · | · | $0 | · | · | · | · | $0 | $12M | $12M | $12M | $11M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Total Liabilities | $37M | $31M | $32M | $28M | $26M | $24M | $26M | · | · | · | $11M | $29M | $47M | $67M | $68M | $63M | |
| Common Stock | $14.0K | $14.0K | $12.0K | $11.0K | $11.0K | $11.0K | $11.0K | $1.0K | $1.0K | $1.0K | $0 | $99.0K | $99.0K | $74.0K | $74.0K | $74.0K | |
| Paid-in Capital | $390M | $383M | $163M | $161M | $159M | $157M | $156M | $343M | $343M | $342M | $2M | $341M | $340M | $319M | $319M | $317M | |
| Retained Earnings | $-173M | $-151M | $-135M | $-123M | $-111M | $-102M | $-94M | $-326M | $-323M | $-320M | $-76M | $-310M | $-300M | $-304M | $-290M | $-282M | |
| AOCI | $89.0K | $95.0K | $83.0K | $104.0K | $-111.0K | $-3.0K | $3.0K | $-316.0K | $-436.0K | $-346.0K | $0 | $-339.0K | $-137.0K | $-426.0K | $-254.0K | $524.0K | |
| Stockholders' Equity | $217M | $232M | $28M | $39M | $48M | $56M | $63M | $16M | $19M | $22M | $-74M | $31M | $40M | $15M | $28M | $36M | |
| Liabilities + Equity | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Shares Outstanding | 14,395,705 | 14,313,659 | 12,380,933 | 11,088,329 | 11,059,665 | 11,021,389 | 11,012,105 | 1,320,240 | 1,320,240 | 1,236,688 | 1,770,167 | · | 98,851,927 | 74,519,103 | 74,519,103 | 74,406,253 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $0 | $0 | $-30.0K | · | $739.0K | $758.0K | $605.0K | $575.0K | $767.0K | |
| Stock-based Comp | $5M | $3M | $2M | $2M | $1M | $1M | $268.0K | $-331.0K | $-109.0K | $146.0K | $-2M | $966.0K | $1M | $884.0K | $949.0K | $974.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-13M | $-11M | $-5M | $-8M | $-5M | $-7M | $-5M | $3M | $4M | $-1M | $20M | $-10M | $-13M | $-11M | $-13M | $-9M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $69.0K | $67.0K | $48.0K | $-11.0K | $34.0K | |
| Investing Cash Flow | $-7M | $-55M | · | · | $0 | $0 | · | $142.0K | $2M | $9M | · | $-2M | $-1M | $12M | $1M | $5M | |
| Stock Issued | $0 | $230M | · | · | $0 | $0 | · | $0 | · | · | · | $0 | $20M | $0 | $0 | $282.0K | |
| Net Stock Activity | · | $230M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $1M | $215M | $-49.0K | $242.0K | $349.0K | $-1M | $75M | $12M | $10M | $0 | $-15M | $0 | $20M | $0 | $93.0K | $282.0K | |
| Net Change in Cash | $-19M | $148M | $-6M | $-7M | $-5M | $-8M | $69M | $5M | $5M | $-1M | $-3M | $-12M | $5M | $1M | $-10M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $-11M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10005.7% | · | -60.5% | 10.3% | -801.2% | · | -226.6% | |
| Net Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | -9230.2% | · | -55.1% | 19.8% | -680.9% | · | -181.3% | |
| Pretax Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10062.3% | · | -60.5% | 10.3% | -769.9% | · | -226.6% | |
| ROA | -13.4% | -9.2% | · | -25.9% | -19.2% | -15.0% | · | -7.2% | -6.4% | -8.8% | · | -13.6% | 3.9% | -12.0% | · | -7.4% | |
| ROE | -16.5% | -10.9% | · | -41.3% | -28.5% | -21.1% | · | -12.3% | -12.1% | -26.2% | · | -32.5% | 9.4% | -38.3% | · | -21.7% | |
| ROIC | -9.9% | -6.4% | · | -26.3% | -19.4% | -14.2% | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.2 | 28.9 | · | 6.5 | 7.7 | 8.8 | · | · | · | · | · | 2.0 | 1.9 | 1.4 | · | 2.3 | |
| Quick Ratio | 21.0 | 28.7 | · | 6.2 | 7.3 | 8.4 | · | 4.6 | 3.3 | 2.8 | · | 1.6 | 1.6 | 1.2 | · | 2.1 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.2 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 3.4 | 0.9 | 0.8 | · | 0.0 | 0.0 | 0.0 | · | 20.8 | 18.1 | 1.4 | · | 1.4 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | · | $20M | $20M | $20M | · | $20M | $40M | $42M | · | $47M | $31M | $22M | · | $24M | |
| Net Income TTM | $-58M | $-45M | · | $-36M | $-29M | $-22M | · | $-24M | $-13M | $-22M | · | $-30M | $-29M | $-38M | · | $-42M | |
| Market Cap | $2.20B | $1.78B | · | $695M | $249M | $308M | · | $22M | $13M | $18M | · | · | $1.31B | $5.82B | · | $6.85B | |
| P/E | -33.1 | -32.5 | · | -9.5 | -2.8 | -3.2 | · | -1.0 | -1.1 | · | · | · | · | -111.5 | · | -131.4 | |
| P/S | 112.4 | 91.2 | · | 35.5 | 12.7 | 15.8 | · | 1.1 | 0.3 | 0.4 | · | · | 42.3 | 264.6 | · | 283.9 | |
| P/B | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Tangible Book | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Cash Flow | · | -164.2 | · | · | · | -45.6 | · | · | · | -2.6 | · | · | · | -529.1 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -2.6 | · | · | · | -526.8 | · | · | |
| Earnings Yield | -3.0% | -3.1% | · | -10.5% | -35.5% | -31.1% | · | -100.4% | -92.7% | · | · | · | · | -0.90% | · | -0.76% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | — | — | $43M | $26M | $31M |
| Betriebsgewinnmarge % | -1490.4% | — | — | -167.8% | — |
| Nettoergebnis | $-42M | $-17M | $19M | $-33M | $-46M |
| Verwässerte EPS | $-3.71 | $-7.83 | $2.17 | — | $-0.71 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.2 | 7.3 | — | 2.0 | — |
| Quick Ratio | 5.1 | 7.0 | — | 1.8 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | — | — | $-61M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 211 Einreicher · $1.9B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 43 (-20 vs. Vorquartal) | 19 (-3 vs. Vorquartal) | 86 (+21 vs. Vorquartal) | 46 (+13 vs. Vorquartal) | +1.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $173.512.745 | 1.135.406 | 9,19% | Aktien |
| Frazier Life Sciences Management, L.P. | $134.848.368 | 882.400 | 7,15% | Aktien |
| JENNISON ASSOCIATES LLC | $124.781.044 | 816.523 | 6,61% | Aktien |
| First Light Asset Management, LLC | $117.961.911 | 771.901 | 6,25% | Aktien |
| BVF INC/IL | $102.815.615 | 672.789 | 5,45% | Aktien |
| STATE STREET CORP | $99.817.745 | 653.172 | 5,29% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $78.517.999 | 513.794 | 4,16% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $73.175.272 | 478.833 | 3,88% | Aktien |
| FEDERATED HERMES, INC. | $66.173.352 | 433.015 | 3,51% | Aktien |
| VANGUARD GROUP INC | $51.885.966 | 495.710 | 2,75% | Aktien |
| Woodline Partners LP | $48.522.948 | 317.517 | 2,57% | Aktien |
| ORBIMED ADVISORS LLC | $44.678.455 | 292.360 | 2,37% | Aktien |
| Siren, L.L.C. | $39.348.858 | 257.485 | 2,09% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $39.149.734 | 256.182 | 2,07% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $36.385.548 | 238.031 | 1,93% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $35.375.385 | 231.484 | 1,87% | Aktien |
| EMERALD ADVISERS, LLC | $35.070.051 | 229.486 | 1,86% | Aktien |
| FMR LLC | $32.814.733 | 214.728 | 1,74% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $31.557.391 | 253.168 | 1,67% | Aktien |
| MPM BIOIMPACT LLC | $31.179.406 | 204.027 | 1,65% | Aktien |
| GOLDMAN SACHS GROUP INC | $28.993.469 | 189.723 | 1,54% | Aktien |
| First Turn Management, LLC | $23.908.689 | 156.450 | 1,27% | Aktien |
| Bellevue Group AG | $23.687.100 | 155.000 | 1,26% | Aktien |
| Caption Management, LLC | $21.394.800 | 140.000 | 1,13% | Verkaufsoption |
| EMERALD MUTUAL FUND ADVISERS TRUST | $19.843.219 | 129.847 | 1,05% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.707.973 | 128.962 | 1,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.430.092 | 120.600 | 0,98% | Kaufoption |
| Aberdeen Group plc | $18.374.771 | 120.238 | 0,97% | Aktien |
| NEXTBio Capital Management LP | $13.739.893 | 89.909 | 0,73% | Aktien |
| Clio Asset Management LLC | $13.194.937 | 86.343 | 0,70% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.706.012 | 76.600 | 0,62% | Verkaufsoption |
| VANGUARD FIDUCIARY TRUST CO | $11.307.916 | 73.995 | 0,60% | Aktien |
| Avidity Partners Management LP | $10.697.400 | 70.000 | 0,57% | Aktien |
| AWM Investment Company, Inc. | $10.608.153 | 69.416 | 0,56% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $9.169.200 | 60.000 | 0,49% | Aktien |
| Clearbridge Investments, LLC | $9.068.458 | 59.341 | 0,48% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $8.445.444 | 55.264 | 0,45% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $8.140.721 | 53.270 | 0,43% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.979.038 | 52.212 | 0,42% | Aktien |
| Ensign Peak Advisors, Inc | $7.894.681 | 51.660 | 0,42% | Aktien |
| Nicholas Investment Partners, LP | $7.597.905 | 49.718 | 0,40% | Aktien |
| Balyasny Asset Management L.P. | $6.805.992 | 44.536 | 0,36% | Aktien |
| Lisanti Capital Growth, LLC | $6.567.440 | 42.975 | 0,35% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $6.215.278 | 40.140 | 0,33% | Aktien |
| ROYCE & ASSOCIATES LP | $6.190.585 | 40.509 | 0,33% | Aktien |
| ORBIMED ADVISORS LLC | $6.112.800 | 40.000 | 0,32% | Kaufoption |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $6.092.169 | 39.865 | 0,32% | Aktien |
| Apis Capital Advisors, LLC | $5.959.980 | 39.000 | 0,32% | Aktien |
| Blue Owl Capital Holdings LP | $5.541.100 | 36.259 | 0,29% | Aktien |
| FIFTH THIRD BANCORP | $5.438.100 | 35.585 | 0,29% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.979.334 | 32.583 | 0,26% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $4.802.216 | 31.424 | 0,25% | Aktien |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $4.786.017 | 31.318 | 0,25% | Aktien |
| CITADEL ADVISORS LLC | $4.645.728 | 30.400 | 0,25% | Kaufoption |
| Caption Management, LLC | $4.584.600 | 30.000 | 0,24% | Kaufoption |
| BANK OF AMERICA CORP /DE/ | $4.577.265 | 29.952 | 0,24% | Aktien |
| JANE STREET GROUP, LLC | $4.095.576 | 26.800 | 0,22% | Kaufoption |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3.820.500 | 25.000 | 0,20% | Aktien |
| NOMURA HOLDINGS INC | $3.662.026 | 23.963 | 0,19% | Aktien |
| Legato Capital Management LLC | $3.589.741 | 23.490 | 0,19% | Aktien |
| TD Asset Management Inc | $3.476.044 | 22.746 | 0,18% | Aktien |
| ACT CAPITAL MANAGEMENT, LLC | $3.438.450 | 22.500 | 0,18% | Aktien |
| Swiss National Bank | $2.964.708 | 19.400 | 0,16% | Aktien |
| Informed Momentum Co LLC | $2.880.504 | 18.849 | 0,15% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $2.762.833 | 18.079 | 0,15% | Aktien |
| F/m Investments LLC | $2.666.098 | 17.446 | 0,14% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.658.610 | 17.397 | 0,14% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.375.587 | 15.545 | 0,13% | Aktien |
| CITIGROUP INC | $2.270.905 | 14.860 | 0,12% | Aktien |
| ALPS ADVISORS INC | $2.193.884 | 14.356 | 0,12% | Aktien |
| Capricorn Fund Managers Ltd | $2.152.928 | 14.088 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $2.067.339 | 13.528 | 0,11% | Aktien |
| Trexquant Investment LP | $2.062.306 | 13.495 | 0,11% | Aktien |
| CITADEL ADVISORS LLC | $2.032.506 | 13.300 | 0,11% | Verkaufsoption |
| BlackRock, Inc. | $1.945.093 | 12.728 | 0,10% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.878.769 | 12.294 | 0,10% | Aktien |
| OAK RIDGE INVESTMENTS LLC | $1.839.647 | 12.038 | 0,10% | Aktien |
| Cresset Asset Management, LLC | $1.777.144 | 11.629 | 0,09% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $1.762.167 | 11.531 | 0,09% | Aktien |
| Rafferty Asset Management, LLC | $1.736.188 | 11.361 | 0,09% | Aktien |
| Bank of New York Mellon Corp | $1.633.340 | 10.688 | 0,09% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $1.593.913 | 10.430 | 0,08% | Aktien |
| Mariner, LLC | $1.583.364 | 10.361 | 0,08% | Aktien |
| Knights of Columbus Asset Advisors LLC | $1.532.937 | 10.031 | 0,08% | Aktien |
| XTX Topco Ltd | $1.354.138 | 8.861 | 0,07% | Aktien |
| MARTINGALE ASSET MANAGEMENT L P | $1.284.605 | 8.406 | 0,07% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $1.208.195 | 7.906 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $978.812 | 6.405 | 0,05% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $977.895 | 6.399 | 0,05% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $976.825 | 6.392 | 0,05% | Aktien |
| Vanguard Global Advisers, LLC | $948.859 | 6.209 | 0,05% | Aktien |
| ASPIRIANT, LLC | $894.303 | 5.852 | 0,05% | Aktien |
| PROFUND ADVISORS LLC | $879.173 | 5.753 | 0,05% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $873.519 | 5.716 | 0,05% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $859.462 | 6.895 | 0,05% | Aktien |
| Penn Capital Management Company, LLC | $841.427 | 5.506 | 0,04% | Aktien |
| ExodusPoint Capital Management, LP | $839.593 | 5.494 | 0,04% | Aktien |
| Squarepoint Ops LLC | $790.996 | 5.176 | 0,04% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $787.176 | 5.151 | 0,04% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $722.991 | 4.731 | 0,04% | Aktien |
Unternehmensinsider 23 Insider · 10 Führungskräfte · 15 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kaupinen Wes | President and CEO | 5. Februar 2026 A | — | 0 | 0 | $0 |
| Stephen S. Yoder | Chief Executive Officer | 23. Februar 2017 A | 6.000 | 0 | 0 | $0 |
| Matthew E Korenberg | CFO, Treasurer | 12. Juni 2026 M | 1.000 | 0 | 0 | $0 |
| Allan Reine | SVP and Chief Financial Officer | 17. August 2017 P | 65.000 | 0 | 0 | $0 |
| Darlene M Deptula-Hicks | SVP, Chief Financial Officer | 13. Juni 2016 P | 5.000 | 0 | 0 | $0 |
| Kathleen Goin | Chief Operating Officer | 15. Juli 2026 M | 0 | 0 | 25 | $-4.196.766 |
| Ashley Hartmann Kline | Chief Commercial Officer | 5. Februar 2026 A | — | 0 | 0 | $0 |
| Jeffrey S Martini | Chief Scientific Officer | 5. Februar 2026 A | — | 0 | 0 | $0 |
| Louis Matis | SVP, Chief Development Officer | 23. Februar 2017 A | 10.000 | 0 | 0 | $0 |
| Claude Knopf | Chief Business Officer | 28. November 2016 A | — | 0 | 0 | $0 |
| Matthew Pauls | Direktor | 29. Juni 2026 A | — | 0 | 0 | $0 |
| Tadd S. Wessel | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| John Doux | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Todd C Davis | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| George M Jenkins | Direktor | 10. Juni 2026 A | 187.616 | 2 | 0 | $549.974 |
| Christopher P Kiritsy | Direktor | 10. Juni 2026 A | 5.000 | 0 | 0 | $0 |
| Elaine J Heron | Direktor | 10. Juni 2026 A | 47.812 | 1 | 0 | $300.000 |
| James A Geraghty | Direktor | 17. August 2017 P | 10.000 | 0 | 0 | $0 |
| Chau Quang Khuong | Direktor | 25. Juli 2017 A | 65.398 | 0 | 0 | $0 |
| Michael Richman | Direktor | 25. Juli 2017 A | — | 0 | 0 | $0 |
| Jean-Pierre Bizzari | Direktor | 25. Januar 2017 A | — | 0 | 0 | $0 |
| Steven Prelack | Direktor | 25. Januar 2017 A | — | 0 | 0 | $0 |
| Julian Adams | Direktor | 25. Januar 2017 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Kaupinen Wes, Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Christine L. Kaupinen, Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Michael Christopher | 20. Dezember 2024 | 14,60% | Erste Einreichung | — | SEC |
| Biotechnology Value Fund, L.P., BVF I GP LLC, Biotechnology Value Fund II, L.P., BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP Holdings LLC, BVF Partners L.P., BVF Inc., Mark N. Lampert ×2 Einreichungen | 17. August 2023 | — | Erste Einreichung | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP III LLC ×10 Einreichungen | 27. September 2018 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 30 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 1,95% | 17.254 NS | 31. Mai 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 1,03% | 14.096 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,96% | 2.798 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,39% | 15.705 NS | 30. April 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,18% | 22.955 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,10% | 98.816 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 11.762 SH | 8. August 2026 | Täglich |
| SMMV · iShares Trust | 0,09% | 1.761 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,05% | 277.644 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 63.184 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,05% | 4.017 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 3.330 NS | 30. April 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 1.578 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,02% | 450 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,02% | 364 NS | 31. Mai 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 1.030 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 4.496 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 113.556 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 30.157 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 667 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 285 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 288 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 3.843 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 7 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 232 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 3.380 SH | 8. August 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 14.741 SH | 8. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 218 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 388.390 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 904 SH | 8. August 2026 | Täglich |